Blog

New E-Book on IVRT and IVPT for topical and transdermal drugs

Posted May 24, 2016

Did you know that the topical and transdermal drug industry is expected to reach $60 billion in the U.S.? As this market continues to grow, the FDA is increasingly emphasizing the use of In Vitro Release Testing (IVRT) and In Vitro Permeation Testing (IVPT) for new submissions.

The problem is that many companies are unsure what steps need to be taken to incorporate these complex test methods into their existing drug development program.

Find out exactly what you need to do to ensure FDA compliance for your topical/transdermal drug submission by downloading our comprehensive, newly updated IVRT/IVPT E-Book.

In this free e-book, you will learn:

  • Available testing methods for topical and transdermal drugs - and what you need for FDA compliance
  • Benefits of IVRT/IVPT for semisolid dosage forms
  • Best practices you can use today to advance your drug development program


Back to Blog list